ArticleBiosensors2025
Evaluating the Suitability of Perfusion-Based PD Probes for Use in Altered Gravity Environments.
Article in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Measurable changes in electrophysiology have been documented in spaceflight, creating a pathway for disease genesis and progression in astronauts. These electrophysiology changes can be measured using potential difference (PD). A probe to measure PD was developed and is used clinically on Earth; this probe relies on fluid perfusion to establish an electrical connection to make PD measurements. The changes to fluid behavior in microgravity and partial gravity (including lunar and Martian gravity) drives the need to test this probe in a spaceflight environment. Here, we test the PD probe in a novel nasal cavity phantom in parabolic flight, simulating microgravity, lunar gravity, Martian gravity, and hypergravity conditions across 37 parabolas. The results are evaluated across gravity conditions using the Wilcoxon Rank Sum test. We record no statistically significant difference in probe PD measurements in 1 g, microgravity, lunar gravity, and hypergravity (approximately 1.8 g) conditions, reaching a NASA Technology Readiness Level 6. Martian gravity findings are inconclusive. Perfusion-based PD probes are therefore successfully demonstrated for use in spaceflight operation in microgravity, lunar gravity, and hypergravity environments; this establishes a foundation for moving towards the in-space testing of perfusion-based probes in astronauts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.